J Eyer-Joel
Angers, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Investigating the functionalization of liposomes with NFL-TBS. 40-63 peptide as a promising drug delivery system.
Journal: International journal of pharmaceutics
Published: April 15, 2023
The use of liposomes functionalized with the NFL-TBS.40-63 peptide as a targeting agent to cross the in vitro blood-brain barrier and target glioblastoma cells.
Journal: International journal of pharmaceutics
Published: April 15, 2023
Fludioxonil, a phenylpyrrol pesticide, induces Cytoskeleton disruption, DNA damage and apoptosis via oxidative stress on rat glioma cells.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: August 17, 2022
Epoxiconazole profoundly alters rat brain and properties of neural stem cells.
Journal: Chemosphere
Published: May 28, 2021
Effect of the NFL-TBS.40-63 peptide on canine glioblastoma cells.
Journal: International journal of pharmaceutics
Published: January 27, 2021
Neuroprotective effects of Myricetin on Epoxiconazole-induced toxicity in F98 cells.
Journal: Free radical biology & medicine
Published: September 08, 2020
The NFL-TBS.40-63 peptide targets and kills glioblastoma stem cells derived from human patients and also targets nanocapsules into these cells.
Journal: International journal of pharmaceutics
Published: January 25, 2019
Cytotoxic and genotoxic effects of epoxiconazole on F98 glioma cells.
Journal: Chemosphere
Published: November 30, 2018
NFL-lipid nanocapsules for brain neural stem cell targeting in vitro and in vivo.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 20, 2016
The Neurofilament-Derived Peptide NFL-TBS.40-63 Targets Neural Stem Cells and Affects Their Properties.
Journal: Stem cells translational medicine
Published: August 27, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026